• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

首例人体胸骨后导线取出术。

First in Human Substernal Lead Extraction.

作者信息

Bodin Alexandre, Nasarre Mathieu, Pierre Bertrand, Clementy Nicolas, Bisson Arnaud

机构信息

Cardiology Service, Regional University Hospital Center of Tours, Tours, France.

Cardiology Service, Le Millénaire Private Hospital, Montpellier, France.

出版信息

JACC Case Rep. 2024 Sep 4;29(17):102485. doi: 10.1016/j.jaccas.2024.102485.

DOI:10.1016/j.jaccas.2024.102485
PMID:39359499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11442165/
Abstract

A 49-year-old male patient underwent substernal lead removal 2.5 years after implantation. The workflow of the procedure and our experience are described in this case report.

摘要

一名49岁男性患者在植入胸骨后导线2.5年后接受了导线取出术。本病例报告描述了该手术的流程及我们的经验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/95d1b4efd21c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/80e41ebffa87/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/a48ca2933f20/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/9c65e21d7d33/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/95d1b4efd21c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/80e41ebffa87/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/a48ca2933f20/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/9c65e21d7d33/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5565/11442165/95d1b4efd21c/gr3.jpg

相似文献

1
First in Human Substernal Lead Extraction.首例人体胸骨后导线取出术。
JACC Case Rep. 2024 Sep 4;29(17):102485. doi: 10.1016/j.jaccas.2024.102485.
2
Three-year extraction experience of a novel substernal extravascular defibrillation lead in sheep.新型胸骨下血管外除颤电极导线在绵羊体内 3 年的取出经验。
Pacing Clin Electrophysiol. 2022 Mar;45(3):314-322. doi: 10.1111/pace.14451. Epub 2022 Feb 8.
3
Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies.胸骨下除颤导线综合分析：EV ICD Pilot、Pivotal 和持续接入研究的经验。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae225.
4
First-in-Human Chronic Implant Experience of the Substernal Extravascular Implantable Cardioverter-Defibrillator.首例经胸骨下入路植入式体外心脏除颤器的人体慢性植入经验。
JACC Clin Electrophysiol. 2020 Nov;6(12):1525-1536. doi: 10.1016/j.jacep.2020.05.029. Epub 2020 Aug 26.
5
The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device-based treatment of sudden cardiac arrest.经胸骨下心外膜导联除颤器的发展：基于器械治疗心搏骤停的新前沿。
J Cardiovasc Electrophysiol. 2022 Jun;33(6):1085-1095. doi: 10.1111/jce.15511. Epub 2022 May 8.
6
Substernal Extravascular Implantable Cardioverter-Defibrillator System Infections in Large Animals.胸骨下血管外植入式心脏复律除颤器系统在大型动物中的感染。
Int Heart J. 2023 Jul 29;64(4):724-731. doi: 10.1536/ihj.22-553. Epub 2023 Jul 14.
7
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.经长期随访的血管外植入式心脏复律除颤器的性能与安全性：关键研究的最终结果
Circulation. 2025 Jan 28;151(4):322-332. doi: 10.1161/CIRCULATIONAHA.124.071795. Epub 2024 Sep 26.
8
Therapy From a Novel Substernal Lead: The ASD2 Study.经胸前皮下植入新型导线的治疗：ASD2 研究。
JACC Clin Electrophysiol. 2019 Feb;5(2):186-196. doi: 10.1016/j.jacep.2018.11.003. Epub 2018 Dec 26.
9
The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy.血管外植入式心律转复除颤器：影响胸骨下植入和除颤效果的解剖参数特征。
Europace. 2022 May 3;24(5):762-773. doi: 10.1093/europace/euab243.
10
Substernal ICD lead implantation in a patient not suitable for subcutaneous ICD implantation without venous access due to superior vena cava syndrome.对于因上腔静脉综合征而不适合进行皮下植入式心律转复除颤器（ICD）植入且无静脉通路的患者，进行胸骨后ICD导线植入。
HeartRhythm Case Rep. 2016 Sep 28;3(1):97-99. doi: 10.1016/j.hrcr.2016.09.013. eCollection 2017 Jan.

本文引用的文献

1
Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high-volume center experience.经静脉取出起搏器和植入式心脏复律除颤器导线的结果和所需工具比较：单一大容量中心经验的见解。
J Cardiovasc Electrophysiol. 2024 Jul;35(7):1382-1392. doi: 10.1111/jce.16294. Epub 2024 May 9.
2
Procedure, management, and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice.在临床实践中皮下植入式心律转复除颤器取出术的程序、管理和结果。
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad158.
3
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
经静脉植入式心脏复律除颤器的疗效和安全性。
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
4
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.皮下与经静脉植入式心脏除颤器治疗的比较：随机试验和倾向评分匹配研究的系统评价和荟萃分析。
J Am Heart Assoc. 2022 Jun 7;11(11):e024756. doi: 10.1161/JAHA.121.024756. Epub 2022 Jun 3.
5
Three-year extraction experience of a novel substernal extravascular defibrillation lead in sheep.新型胸骨下血管外除颤电极导线在绵羊体内 3 年的取出经验。
Pacing Clin Electrophysiol. 2022 Mar;45(3):314-322. doi: 10.1111/pace.14451. Epub 2022 Feb 8.
6
Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.经静脉植入式心脏除颤器导线相关并发症的危险因素和时间趋势。
J Am Heart Assoc. 2018 May 10;7(10):e007691. doi: 10.1161/JAHA.117.007691.